[HT-03-3] Gepants and lasmiditan: novel players in acute migraine treatment
Although triptans and some prophylactic medications are currently available, some unmet needs of migraine managements remain to be resolved. Now some lineup of new molecules, devices and methods are developing to be served for practical clinical settings. This symposium will review the new lineups by top headache experts.
1986-1992Keio University School of Medicine
1992-1996Keio University Graduate School of Medicine
1996-2002Instructor, Department of Neurology, Keio University School of Medicine
2002-2005Postdoctoral Fellow, Department of Cell Biology, Harvard Medical School
2005-2006Instructor, Department of Neurology, Keio University School of Medicine
2006-2008Staff Physician, Department of Neurology, National Hospital Organization Tokyo Medical Center
2008-2019Assistant Professor, Department of Neurology, Keio University School of Medicine
2019-presentAssociate Professor, Department of Neurology, Keio University School of Medicine
Research interests: headache medicine, migraine pathophysiology, neurodegeneration, autophagy
抄録パスワード認証
パスワードは抄録集に記載してあります。